Janet Mary Fauls
Keine laufenden Positionen mehr
Profil
Janet Mary Fauls worked as VP-Regulatory, Quality & Clinical Affairs at CardioGenesis Corp.
from 2001 to 2005.
She also worked as VP-Regulatory & Clinical Affairs at Endologix LLC in 2012.
Fauls completed her undergraduate degree from the University of California, Santa Barbara.
Ehemalige bekannte Positionen von Janet Mary Fauls
| Unternehmen | Position | Ende |
|---|---|---|
CardioGenesis Corp.
 CardioGenesis Corp. Medical SpecialtiesHealth Technology Cardiogenesis Corp. designs, develops, and distributes surgical products for the treatment of refractory angina in patients with chronic cardiac ischemia caused by coronary artery disease. The company was founded by Randy J. Kesten in April 1989 and is headquartered in Irvine, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2005 |
| ENDOLOGIX, INC. | General Counsel | - |
Ausbildung von Janet Mary Fauls
| University of California, Santa Barbara | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
CardioGenesis Corp.
CardioGenesis Corp. Medical SpecialtiesHealth Technology Cardiogenesis Corp. designs, develops, and distributes surgical products for the treatment of refractory angina in patients with chronic cardiac ischemia caused by coronary artery disease. The company was founded by Randy J. Kesten in April 1989 and is headquartered in Irvine, CA. | Health Technology |
Endologix LLC
 Endologix LLC Medical SpecialtiesHealth Technology Endologix LLC engages in the research, development, manufacture, and trade of medical devices for the treatment of aortic disorders such as abdominal aortic aneurysms (AAA). Its products include AFX Endovascular AAA System, Nellix and Ovation. The company was founded in March 1992 and is headquartered in Irvine, CA. | Health Technology |
